Vessel Shrinkage and Stroke Recurrence in Intracranial Atherosclerotic Stenosis Under Intensive Lipid-Lowering Therapy
Stroke · 2025
DOI: 10.1161/strokeaha.125.051719 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Stroke, 2025. Verfasst von Weizhuang Yuan und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases (W.Y., X.H., Caiyan Liu, Y.X., W.-H.X.), Peking Union Medical Colle…. Hauptthemen laut MEDLINE: Intracranial Arteriosclerosis, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Ischemic Stroke, Stroke. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
BACKGROUND: Little is known about the dynamic process of the outer-wall boundary during intensive lipid-lowering therapy in patients with intracranial atherosclerotic stenosis and its clinical implications. METHODS: We analyzed patients with first-ever acute ischemic stroke attributed to intracranial atherosclerotic stenosis who received intensive lipid-lowering therapy with high-dose statins or PCSK9i (proprotein convertase subtilisin/kexin type 9 inhibitor). Data were obtained from a multicenter cohort study at 15 hospitals across China and our institutional database in Beijing, China. All patients underwent 3-dimensional T1-weighted high-resolution magnetic resonance vessel wall imaging at baseline and after a >6-month follow-up period. Outer-wall boundary area changes were classified as expansion (>10% increase), shrinkage (>10% decrease), or quiescence (≤10% change). The association between these changes and time to recurrent ipsilateral stroke was assessed. The Kaplan-Meier method and the Cox proportional hazards model were used. RESULTS: Among the 137 patients, 50 (36.5%) exhibited expansion, 40 (29.2%) shrinkage, and 47 (34.3%) quiescence of the outer-wall boundary area. Among these 3 groups, plaque burden decreased significantly between the index imaging and follow-up (all P ≤ 0 .02). Lumen area increased significantly in patients with expansion ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases (W.Y., X.H., Caiyan Liu, Y.X., W.-H.X.), Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medic…
- Department of Neurology, Jining No. 1 People's Hospital, China (Z.Y.).
- Department of Neurology, Tangshan Gongren Hospital, China (B.L.).
- Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China (X.L.).
- Department of Neurology, Tongren Hospital, Shanghai Jiaotong University School of Medicine, China (A.D.).
- Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (D.T.).
ORCID-Profile: Weizhuang Yuan, Le Fang, Bo Wu, Hebo Wang, Mingli Li, Xinzhi Hu, Yue-Lun Zhang, Yan Xu, Wei-Hai Xu
Zitieren
APA
Yuan, W., Yan, Z., Lu, B., Liu, X., Du, A., Tian, D., Fang, L., Liu, C., Liu, G., Wu, B., Wang, H., Gong, T., Shi, Z., Li, M., Hu, X., Liu, C., Zhang, Y. L., Xu, Y., & Xu, W. H. (2025). Vessel Shrinkage and Stroke Recurrence in Intracranial Atherosclerotic Stenosis Under Intensive Lipid-Lowering Therapy. Stroke. https://doi.org/10.1161/strokeaha.125.051719
Vancouver
Yuan W, Yan Z, Lu B, Liu X, Du A, Tian D, et al. Vessel Shrinkage and Stroke Recurrence in Intracranial Atherosclerotic Stenosis Under Intensive Lipid-Lowering Therapy. Stroke. 2025. doi:10.1161/strokeaha.125.051719
BibTeX
@article{Yuan2025,
author = {Yuan, Weizhuang and Yan, Zhongrui and Lu, Baoquan and Liu, Xiaoyun and Du, Ailian and Tian, Daishi and Fang, Le and Liu, Changyun and Liu, Guangzhi and Wu, Bo and Wang, Hebo and Gong, Tao and Shi, Zhimin and Li, Mingli and Hu, Xinzhi and Liu, Caiyan and Zhang, Yue-Lun and Xu, Yan and Xu, Wei-Hai},
title = {Vessel Shrinkage and Stroke Recurrence in Intracranial Atherosclerotic Stenosis Under Intensive Lipid-Lowering Therapy},
journal = {Stroke},
year = {2025},
doi = {10.1161/strokeaha.125.051719}
}
EUVIMED